nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—OPRK1—Progesterone—uterine cancer	0.303	0.427	CbGbCtD
Hydromorphone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0914	0.129	CbGbCtD
Hydromorphone—PTGS1—Etoposide—uterine cancer	0.0673	0.0949	CbGbCtD
Hydromorphone—CYP2C9—Progesterone—uterine cancer	0.0605	0.0854	CbGbCtD
Hydromorphone—CYP2D6—Progesterone—uterine cancer	0.0553	0.078	CbGbCtD
Hydromorphone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0531	0.0749	CbGbCtD
Hydromorphone—CYP3A4—Progesterone—uterine cancer	0.0352	0.0496	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—uterine cancer	0.0169	0.0238	CbGbCtD
Hydromorphone—CYP3A4—Etoposide—uterine cancer	0.0157	0.0222	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—uterine cancer	0.0107	0.0151	CbGbCtD
Hydromorphone—Hypertension—Etoposide—uterine cancer	0.00023	0.00079	CcSEcCtD
Hydromorphone—Osteoarthritis—Doxorubicin—uterine cancer	0.000229	0.000788	CcSEcCtD
Hydromorphone—Pain in extremity—Doxorubicin—uterine cancer	0.000229	0.000788	CcSEcCtD
Hydromorphone—Diplopia—Doxorubicin—uterine cancer	0.000229	0.000788	CcSEcCtD
Hydromorphone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000229	0.000786	CcSEcCtD
Hydromorphone—Chest pain—Etoposide—uterine cancer	0.000227	0.000779	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Epirubicin—uterine cancer	0.000226	0.000778	CcSEcCtD
Hydromorphone—Abdominal pain upper—Epirubicin—uterine cancer	0.000226	0.000778	CcSEcCtD
Hydromorphone—Affect lability—Doxorubicin—uterine cancer	0.000226	0.000776	CcSEcCtD
Hydromorphone—Migraine—Doxorubicin—uterine cancer	0.000226	0.000776	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000225	0.000774	CcSEcCtD
Hydromorphone—Discomfort—Etoposide—uterine cancer	0.000224	0.00077	CcSEcCtD
Hydromorphone—Breast disorder—Epirubicin—uterine cancer	0.000224	0.00077	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000223	0.000767	CcSEcCtD
Hydromorphone—Nasopharyngitis—Epirubicin—uterine cancer	0.000222	0.000762	CcSEcCtD
Hydromorphone—Hypersensitivity—Dactinomycin—uterine cancer	0.000221	0.00076	CcSEcCtD
Hydromorphone—Gastritis—Epirubicin—uterine cancer	0.000219	0.000754	CcSEcCtD
Hydromorphone—Confusional state—Etoposide—uterine cancer	0.000219	0.000753	CcSEcCtD
Hydromorphone—Muscular weakness—Epirubicin—uterine cancer	0.000218	0.000751	CcSEcCtD
Hydromorphone—Cardiac arrest—Doxorubicin—uterine cancer	0.000218	0.00075	CcSEcCtD
Hydromorphone—Anaphylactic shock—Etoposide—uterine cancer	0.000217	0.000747	CcSEcCtD
Hydromorphone—Mood swings—Doxorubicin—uterine cancer	0.000217	0.000747	CcSEcCtD
Hydromorphone—Infection—Etoposide—uterine cancer	0.000216	0.000742	CcSEcCtD
Hydromorphone—Abdominal distension—Epirubicin—uterine cancer	0.000216	0.000741	CcSEcCtD
Hydromorphone—Asthenia—Dactinomycin—uterine cancer	0.000215	0.000741	CcSEcCtD
Hydromorphone—Asthma—Epirubicin—uterine cancer	0.000214	0.000736	CcSEcCtD
Hydromorphone—Dysphagia—Epirubicin—uterine cancer	0.000214	0.000736	CcSEcCtD
Hydromorphone—Dehydration—Doxorubicin—uterine cancer	0.000213	0.000733	CcSEcCtD
Hydromorphone—Tachycardia—Etoposide—uterine cancer	0.000212	0.000729	CcSEcCtD
Hydromorphone—Skin disorder—Etoposide—uterine cancer	0.000211	0.000726	CcSEcCtD
Hydromorphone—Hyperhidrosis—Etoposide—uterine cancer	0.00021	0.000722	CcSEcCtD
Hydromorphone—Abdominal pain upper—Doxorubicin—uterine cancer	0.000209	0.00072	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000209	0.00072	CcSEcCtD
Hydromorphone—Breast disorder—Doxorubicin—uterine cancer	0.000207	0.000712	CcSEcCtD
Hydromorphone—Anorexia—Etoposide—uterine cancer	0.000207	0.000712	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000206	0.00071	CcSEcCtD
Hydromorphone—Diarrhoea—Dactinomycin—uterine cancer	0.000205	0.000706	CcSEcCtD
Hydromorphone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000205	0.000705	CcSEcCtD
Hydromorphone—Hypotension—Etoposide—uterine cancer	0.000203	0.000698	CcSEcCtD
Hydromorphone—Gastritis—Doxorubicin—uterine cancer	0.000203	0.000698	CcSEcCtD
Hydromorphone—Muscular weakness—Doxorubicin—uterine cancer	0.000202	0.000695	CcSEcCtD
Hydromorphone—Dysuria—Epirubicin—uterine cancer	0.0002	0.000689	CcSEcCtD
Hydromorphone—Abdominal distension—Doxorubicin—uterine cancer	0.000199	0.000686	CcSEcCtD
Hydromorphone—Asthma—Doxorubicin—uterine cancer	0.000198	0.000681	CcSEcCtD
Hydromorphone—Dysphagia—Doxorubicin—uterine cancer	0.000198	0.000681	CcSEcCtD
Hydromorphone—Pollakiuria—Epirubicin—uterine cancer	0.000198	0.00068	CcSEcCtD
Hydromorphone—Paraesthesia—Etoposide—uterine cancer	0.000195	0.000671	CcSEcCtD
Hydromorphone—Weight decreased—Epirubicin—uterine cancer	0.000194	0.000666	CcSEcCtD
Hydromorphone—Dyspnoea—Etoposide—uterine cancer	0.000194	0.000666	CcSEcCtD
Hydromorphone—Somnolence—Etoposide—uterine cancer	0.000193	0.000664	CcSEcCtD
Hydromorphone—Infestation NOS—Epirubicin—uterine cancer	0.000191	0.000657	CcSEcCtD
Hydromorphone—Infestation—Epirubicin—uterine cancer	0.000191	0.000657	CcSEcCtD
Hydromorphone—Drowsiness—Epirubicin—uterine cancer	0.000191	0.000657	CcSEcCtD
Hydromorphone—Vomiting—Dactinomycin—uterine cancer	0.000191	0.000656	CcSEcCtD
Hydromorphone—Rash—Dactinomycin—uterine cancer	0.000189	0.000651	CcSEcCtD
Hydromorphone—Decreased appetite—Etoposide—uterine cancer	0.000189	0.000649	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000188	0.000645	CcSEcCtD
Hydromorphone—Fatigue—Etoposide—uterine cancer	0.000187	0.000644	CcSEcCtD
Hydromorphone—Stomatitis—Epirubicin—uterine cancer	0.000186	0.00064	CcSEcCtD
Hydromorphone—Constipation—Etoposide—uterine cancer	0.000186	0.000639	CcSEcCtD
Hydromorphone—Pain—Etoposide—uterine cancer	0.000186	0.000639	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—uterine cancer	0.000185	0.000637	CcSEcCtD
Hydromorphone—Sweating—Epirubicin—uterine cancer	0.000183	0.000629	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—uterine cancer	0.000183	0.000629	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Epirubicin—uterine cancer	0.000181	0.000621	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—uterine cancer	0.000179	0.000616	CcSEcCtD
Hydromorphone—Feeling abnormal—Etoposide—uterine cancer	0.000179	0.000616	CcSEcCtD
Hydromorphone—Nausea—Dactinomycin—uterine cancer	0.000178	0.000613	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Etoposide—uterine cancer	0.000178	0.000611	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Hydromorphone—Bradycardia—Epirubicin—uterine cancer	0.000174	0.0006	CcSEcCtD
Hydromorphone—Urticaria—Etoposide—uterine cancer	0.000173	0.000593	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—uterine cancer	0.000172	0.000592	CcSEcCtD
Hydromorphone—Rhinitis—Epirubicin—uterine cancer	0.000172	0.000591	CcSEcCtD
Hydromorphone—Body temperature increased—Etoposide—uterine cancer	0.000172	0.000591	CcSEcCtD
Hydromorphone—Abdominal pain—Etoposide—uterine cancer	0.000172	0.000591	CcSEcCtD
Hydromorphone—Hypoaesthesia—Epirubicin—uterine cancer	0.00017	0.000586	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—uterine cancer	0.000169	0.000582	CcSEcCtD
Hydromorphone—Urinary tract disorder—Epirubicin—uterine cancer	0.000169	0.000582	CcSEcCtD
Hydromorphone—Oedema peripheral—Epirubicin—uterine cancer	0.000169	0.000581	CcSEcCtD
Hydromorphone—Connective tissue disorder—Epirubicin—uterine cancer	0.000168	0.000579	CcSEcCtD
Hydromorphone—Urethral disorder—Epirubicin—uterine cancer	0.000168	0.000578	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000167	0.000575	CcSEcCtD
Hydromorphone—Visual impairment—Epirubicin—uterine cancer	0.000165	0.000568	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—uterine cancer	0.000161	0.000555	CcSEcCtD
Hydromorphone—Eye disorder—Epirubicin—uterine cancer	0.00016	0.000551	CcSEcCtD
Hydromorphone—Hypersensitivity—Etoposide—uterine cancer	0.00016	0.00055	CcSEcCtD
Hydromorphone—Tinnitus—Epirubicin—uterine cancer	0.00016	0.00055	CcSEcCtD
Hydromorphone—Flushing—Epirubicin—uterine cancer	0.000159	0.000547	CcSEcCtD
Hydromorphone—Cardiac disorder—Epirubicin—uterine cancer	0.000159	0.000547	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—uterine cancer	0.000159	0.000547	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—uterine cancer	0.000158	0.000543	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000157	0.000539	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—uterine cancer	0.000156	0.000537	CcSEcCtD
Hydromorphone—Asthenia—Etoposide—uterine cancer	0.000156	0.000536	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000156	0.000536	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—uterine cancer	0.000155	0.000535	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—uterine cancer	0.000155	0.000535	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—uterine cancer	0.000155	0.000532	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—uterine cancer	0.000154	0.000531	CcSEcCtD
Hydromorphone—Chills—Epirubicin—uterine cancer	0.000154	0.000529	CcSEcCtD
Hydromorphone—Pruritus—Etoposide—uterine cancer	0.000154	0.000528	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—uterine cancer	0.000153	0.000527	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—uterine cancer	0.000153	0.000526	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—uterine cancer	0.00015	0.000516	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—uterine cancer	0.000149	0.000513	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—uterine cancer	0.000149	0.000513	CcSEcCtD
Hydromorphone—Diarrhoea—Etoposide—uterine cancer	0.000149	0.000511	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—uterine cancer	0.000148	0.00051	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—uterine cancer	0.000148	0.000508	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—uterine cancer	0.000147	0.000506	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—uterine cancer	0.000147	0.000506	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—uterine cancer	0.000147	0.000506	CcSEcCtD
Hydromorphone—Tension—Epirubicin—uterine cancer	0.000146	0.000503	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—uterine cancer	0.000146	0.000502	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—uterine cancer	0.000145	0.000498	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—uterine cancer	0.000144	0.000496	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—uterine cancer	0.000144	0.000495	CcSEcCtD
Hydromorphone—Dizziness—Etoposide—uterine cancer	0.000144	0.000494	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—uterine cancer	0.000143	0.000493	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—uterine cancer	0.000143	0.000493	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000143	0.000491	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—uterine cancer	0.000142	0.000489	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—uterine cancer	0.000142	0.000487	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—uterine cancer	0.000141	0.000484	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—uterine cancer	0.000139	0.000478	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—uterine cancer	0.000138	0.000476	CcSEcCtD
Hydromorphone—Vomiting—Etoposide—uterine cancer	0.000138	0.000475	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—uterine cancer	0.000138	0.000475	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—uterine cancer	0.000138	0.000475	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—uterine cancer	0.000137	0.000471	CcSEcCtD
Hydromorphone—Rash—Etoposide—uterine cancer	0.000137	0.000471	CcSEcCtD
Hydromorphone—Dermatitis—Etoposide—uterine cancer	0.000137	0.000471	CcSEcCtD
Hydromorphone—Headache—Etoposide—uterine cancer	0.000136	0.000468	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—uterine cancer	0.000136	0.000468	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—uterine cancer	0.000135	0.000466	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—uterine cancer	0.000135	0.000465	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—uterine cancer	0.000135	0.000463	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—uterine cancer	0.000134	0.000461	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—uterine cancer	0.000134	0.000461	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—uterine cancer	0.000134	0.00046	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—uterine cancer	0.000134	0.000459	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—uterine cancer	0.000134	0.000459	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—uterine cancer	0.000133	0.000456	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—uterine cancer	0.000132	0.000453	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—uterine cancer	0.000131	0.000451	CcSEcCtD
Hydromorphone—Cough—Epirubicin—uterine cancer	0.00013	0.000448	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—uterine cancer	0.00013	0.000447	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—uterine cancer	0.000129	0.000445	CcSEcCtD
Hydromorphone—Nausea—Etoposide—uterine cancer	0.000129	0.000444	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—uterine cancer	0.000129	0.000443	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000128	0.00044	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—uterine cancer	0.000127	0.000437	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—uterine cancer	0.000127	0.000437	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—uterine cancer	0.000127	0.000437	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—uterine cancer	0.000127	0.000436	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—uterine cancer	0.000127	0.000435	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000126	0.000434	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—uterine cancer	0.000125	0.000432	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—uterine cancer	0.000124	0.000428	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—uterine cancer	0.000124	0.000427	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—uterine cancer	0.000124	0.000427	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—uterine cancer	0.000124	0.000426	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—uterine cancer	0.000123	0.000422	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—uterine cancer	0.000122	0.00042	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—uterine cancer	0.000122	0.000419	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—uterine cancer	0.000121	0.000417	CcSEcCtD
Hydromorphone—Infection—Epirubicin—uterine cancer	0.000121	0.000416	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—uterine cancer	0.00012	0.000414	CcSEcCtD
Hydromorphone—Shock—Epirubicin—uterine cancer	0.00012	0.000412	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—uterine cancer	0.00012	0.000411	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—uterine cancer	0.000119	0.000411	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—uterine cancer	0.000119	0.00041	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—uterine cancer	0.000119	0.000409	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—uterine cancer	0.000118	0.000407	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—uterine cancer	0.000118	0.000405	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—uterine cancer	0.000117	0.000403	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000117	0.000401	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—uterine cancer	0.000116	0.000399	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—uterine cancer	0.000116	0.000399	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—uterine cancer	0.000115	0.000395	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—uterine cancer	0.000114	0.000391	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—uterine cancer	0.000114	0.000391	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—uterine cancer	0.000113	0.000387	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—uterine cancer	0.000112	0.000385	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000111	0.000381	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—uterine cancer	0.000111	0.000381	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—uterine cancer	0.00011	0.00038	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—uterine cancer	0.00011	0.000379	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—uterine cancer	0.00011	0.000378	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—uterine cancer	0.000109	0.000376	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—uterine cancer	0.000109	0.000376	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000109	0.000375	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—uterine cancer	0.000109	0.000373	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—uterine cancer	0.000108	0.000372	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—uterine cancer	0.000107	0.000369	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—uterine cancer	0.000107	0.000369	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—uterine cancer	0.000106	0.000364	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—uterine cancer	0.000105	0.000362	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000105	0.000362	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—uterine cancer	0.000105	0.000361	CcSEcCtD
Hydromorphone—Pain—Epirubicin—uterine cancer	0.000104	0.000358	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—uterine cancer	0.000104	0.000358	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000103	0.000353	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—uterine cancer	0.000102	0.00035	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—uterine cancer	0.0001	0.000345	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—uterine cancer	0.0001	0.000345	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—uterine cancer	0.0001	0.000344	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—uterine cancer	9.96e-05	0.000342	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—uterine cancer	9.92e-05	0.000341	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—uterine cancer	9.79e-05	0.000337	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.73e-05	0.000334	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—uterine cancer	9.71e-05	0.000334	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—uterine cancer	9.67e-05	0.000333	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—uterine cancer	9.63e-05	0.000331	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—uterine cancer	9.63e-05	0.000331	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—uterine cancer	9.62e-05	0.000331	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—uterine cancer	9.62e-05	0.000331	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—uterine cancer	9.28e-05	0.000319	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—uterine cancer	9.21e-05	0.000317	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—uterine cancer	8.97e-05	0.000309	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—uterine cancer	8.95e-05	0.000308	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—uterine cancer	8.9e-05	0.000306	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—uterine cancer	8.9e-05	0.000306	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—uterine cancer	8.73e-05	0.0003	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—uterine cancer	8.61e-05	0.000296	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—uterine cancer	8.33e-05	0.000286	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—uterine cancer	8.3e-05	0.000285	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—uterine cancer	8.08e-05	0.000278	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—uterine cancer	8.05e-05	0.000277	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—uterine cancer	7.97e-05	0.000274	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—uterine cancer	7.74e-05	0.000266	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—uterine cancer	7.71e-05	0.000265	CcSEcCtD
Hydromorphone—Rash—Epirubicin—uterine cancer	7.68e-05	0.000264	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—uterine cancer	7.67e-05	0.000264	CcSEcCtD
Hydromorphone—Headache—Epirubicin—uterine cancer	7.63e-05	0.000262	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—uterine cancer	7.45e-05	0.000256	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—uterine cancer	7.23e-05	0.000249	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—uterine cancer	7.16e-05	0.000246	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—uterine cancer	7.1e-05	0.000244	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—uterine cancer	7.1e-05	0.000244	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—uterine cancer	7.06e-05	0.000243	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—uterine cancer	6.69e-05	0.00023	CcSEcCtD
Hydromorphone—PTGS1—oviduct—uterine cancer	2.72e-05	0.141	CbGeAlD
Hydromorphone—UGT1A9—renal system—uterine cancer	2.41e-05	0.125	CbGeAlD
Hydromorphone—OPRD1—renal system—uterine cancer	1.91e-05	0.0988	CbGeAlD
Hydromorphone—PTGS1—artery—uterine cancer	1.8e-05	0.0935	CbGeAlD
Hydromorphone—OPRK1—female reproductive system—uterine cancer	1.46e-05	0.0759	CbGeAlD
Hydromorphone—PTGS1—epithelium—uterine cancer	6.84e-06	0.0354	CbGeAlD
Hydromorphone—PTGS1—uterine cervix—uterine cancer	6.78e-06	0.0351	CbGeAlD
Hydromorphone—PTGS1—smooth muscle tissue—uterine cancer	6.59e-06	0.0342	CbGeAlD
Hydromorphone—PTGS1—renal system—uterine cancer	6.34e-06	0.0329	CbGeAlD
Hydromorphone—PTGS1—endometrium—uterine cancer	6.13e-06	0.0318	CbGeAlD
Hydromorphone—PTGS1—mammalian vulva—uterine cancer	5.93e-06	0.0307	CbGeAlD
Hydromorphone—PTGS1—uterus—uterine cancer	5.65e-06	0.0293	CbGeAlD
Hydromorphone—CYP2C9—female reproductive system—uterine cancer	5.56e-06	0.0288	CbGeAlD
Hydromorphone—CYP3A4—renal system—uterine cancer	5.3e-06	0.0275	CbGeAlD
Hydromorphone—CYP2D6—renal system—uterine cancer	5.21e-06	0.027	CbGeAlD
Hydromorphone—PTGS1—female reproductive system—uterine cancer	5.08e-06	0.0263	CbGeAlD
Hydromorphone—PTGS1—female gonad—uterine cancer	4.62e-06	0.024	CbGeAlD
Hydromorphone—PTGS1—vagina—uterine cancer	4.59e-06	0.0238	CbGeAlD
Hydromorphone—CYP3A4—female reproductive system—uterine cancer	4.24e-06	0.022	CbGeAlD
Hydromorphone—CYP2D6—female reproductive system—uterine cancer	4.18e-06	0.0216	CbGeAlD
Hydromorphone—CYP2D6—female gonad—uterine cancer	3.8e-06	0.0197	CbGeAlD
Hydromorphone—PTGS1—lymph node—uterine cancer	2.97e-06	0.0154	CbGeAlD
